Drugs / Soy isoflavone supplement
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01052116 Comparator | Mar 2010 → Aug 2012 | asthma | American Lung Association Asthma Clinical Research Centers | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Soy isoflavone supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01052116 ↗ |
| Modality | Other / unclassified | “soy isoflavone supplement” NCT01052116 ↗ |
| Route | Oral | “Oral soy isoflavone supplement (100 mg/day)” NCT01052116 ↗ |